AC
EVH icon

Aristides Capital’s Evolent Health EVH Stock Holding History

Aristides Capital’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-48,800
Closed -$195K – 204
2025
Q4 		$195K Buy
+48,800
New +$271K 0.03% 187
2025
Q1 		– Sell
-18,600
Closed -$209K – 259
2024
Q4 		$209K Buy
+18,600
New +$327K 0.04% 228
2020
Q1 		– Sell
-25,281
Closed -$229K – 184
2019
Q4 		$229K Buy
+25,281
New +$205K 0.18% 144

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Aristides Capital's EVH Position: Q1 2026 in Review

Aristides Capital sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 48,800 shares — an estimated $195K sold.

Aristides Capital first reported a position in EVH in Q4 2019 and held it in 3 quarters. The position peaked at $229K in Q4 2019. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Aristides Capital reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Aristides Capital sold 48,800 Evolent Health shares in Q1 2026, an estimated $195K.
  • Aristides Capital first reported a position in Evolent Health in Q4 2019 and held it in 3 quarters.
  • Aristides Capital's Evolent Health position peaked at $229K in Q4 2019.
  • 192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Aristides Capital's 13F filing for Q1 2026, filed 14 May 2026.